Clinical Trials for Brain cancer

Clinical trials are research studies conducted in an effort to improve overall patient health and care. Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition. Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks. A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.

A brief description of each phase:

• Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
• Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
• Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
• Phase IV: These studies monitor long-term side effects after the treatment has been marketed.

Clinical Trials data for Brain cancer is grouped into the following categories:-

• View by trial name
• View by drugs used in Brain cancer clinical trials

Clinical Trials by trial name

The format for each of the following is:

• The name of the trial,
• followed by whether the trial is recruiting patients,
  - The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
  - Note**: Please follow the link to determine the current trial status.
• followed by a list of drug/s, if any, used in the trial

ClinicalTrials.gov has listed the following trials for Brain cancer:

• Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - gadopentetate dimeglumine
• MR Guided Laser Interstitial Thermal Therapy for the Minimal Invasive Treatment of Brain Metastasis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006) - sargramostim,telomerase: 540-548 peptide vaccine
• Hypertonic Saline 75% Vs Mannitol 20% - This study is currently recruiting patients (Current: 23 Nov 2006) - Administration of Hypertonic Solution 7.5% vs Mannitol 20%
• Fluorescence-Guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid - This study has been completed (Current: 23 Nov 2006) - 5-aminolevulinic acid
• Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) - This study is no longer recruiting patients (Current: 23 Nov 2006) - Motexafin Gadolinium
• Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases - This study is currently recruiting patients (Current: 23 Nov 2006) - Motexafin gadolinium
• Phase III Trial of Postoperative WBRT Vs. Salvage SRT for One to Four Brain Metastasis. JCOG0504 - This study is currently recruiting patients (Current: 23 Nov 2006)
• Study of Karenitecin (BNP1350) in Patients With Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - Karenitecin (BNP1350)
• Safety Study of Intracerebral Topotecan for Recurrent Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - Topotecan
• Study on Amino Acid Uptake in Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - O-(2-[F-18]Fluorethyl)-L-Tyrosin (FET) - PET
• Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - calcitriol,carboplatin
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers - This study has been completed (Current: 23 Nov 2006) - iodine I 131 monoclonal antibody 81C6
• Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas - This study is no longer recruiting patients (Current: 23 Nov 2006) - iodine I 131 monoclonal antibody 81C6
• Monoclonal Antibody Therapy in Patients With Primary or Metastatic Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - monoclonal antibody Me1-14 F(ab')2
• Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - chemoprotection,bone marrow ablation with stem cell support,amifostine,busulfan,filgrastim,melphalan,thiotepa
• Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - filgrastim,lomustine,procarbazine,vincristine
• Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - autologous lymphocytes,autologous tumor cell vaccine,carmustine,cisplatin,cyclophosphamide,filgrastim,interleukin-2,paclitaxel,sargramostim
• Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,etoposide,filgrastim,ifosfamide,recombinant human thrombopoietin
• Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - carmustine,iodine I 131 monoclonal antibody 81C6,irinotecan
• High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - bone marrow ablation with stem cell support,filgrastim,thiotepa
• Carboplatin in Patients With Progressive Gliomas - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin
• A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006) - Motexafin Gadolinium Injection
• Gene Therapy in Treating Patients With Primary Brain Tumors - This study has been completed (Current: 23 Nov 2006) - ganciclovir
• Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - ecteinascidin 743
• Procarbazine in Treating Patients With Recurrent Brain Tumor - This study has been completed (Current: 23 Nov 2006) - procarbazine
• Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - octreotide,yttrium Y 90 SMT 487
• Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,cyclophosphamide,etoposide,filgrastim
• Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors - This study has been completed (Current: 23 Nov 2006) - gallium nitrate
• Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - interleukin-2,interleukin-2/tumor infiltrating lymphocytes,monoclonal antibody OKT3,tumor infiltrating lymphocytes
• Suramin in Treating Patients With Recurrent Primary Brain Tumors - This study has been completed (Current: 23 Nov 2006) - suramin
• Combination Chemotherapy for Patients With Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - filgrastim,paclitaxel,topotecan
• Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - lomustine,procarbazine,vincristine
• Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,etoposide
• Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas - This study is no longer recruiting patients (Current: 23 Nov 2006) - interferon alfa
• O(6)-Benzylguanine in Treating Patients With Malignant Glioma - This study has been completed (Current: 23 Nov 2006) - O6-benzylguanine
• Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - carmustine,irinotecan
• Irinotecan in Treating Patients With Recurrent Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - irinotecan
• Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - carmustine,temozolomide
• Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors - This study has been completed (Current: 23 Nov 2006) - phenylacetate
• SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme - This study has been completed (Current: 23 Nov 2006) - leflunomide,procarbazine
• Irinotecan in Treating Patients With Recurrent Malignant Glioma - This study has been completed (Current: 23 Nov 2006) - irinotecan
• Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain - This study is no longer recruiting patients (Current: 23 Nov 2006) - carmustine,O6-benzylguanine
• Topotecan in Treating Patients With Recurrent Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - topotecan
• Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas - This study has been completed (Current: 23 Nov 2006) - carmustine,irinotecan,polifeprosan 20 with carmustine implant
• Temozolomide in Treating Patients With Anaplastic Oligodendroglioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - temozolomide
• Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas - This study is no longer recruiting patients (Current: 23 Nov 2006) - isotretinoin,procarbazine
• Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors - This study has been completed (Current: 23 Nov 2006) - iodine I 125
• Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma - This study has been completed (Current: 23 Nov 2006) - irinotecan
• CCI-779 in Treating Patients With Advanced Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - CCI-779
• Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse - This study is no longer recruiting patients (Current: 23 Nov 2006) - leflunomide
• IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - interleukin-4 PE38KDEL immunotoxin
• Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma - This study has been completed (Current: 23 Nov 2006) - iodine I 125,iodine I 125/polifeprosan 20 with carmustine implant,polifeprosan 20 with carmustine implant
• Gene Therapy in Treating Patients With Recurrent Malignant Gliomas - This study has been completed (Current: 23 Nov 2006) - adenovirus p53
• Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors - This study has been completed (Current: 23 Nov 2006) - SCH-58500
• Temozolomide in Treating Patients With Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - temozolomide
• Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - temozolomide
• SU5416 in Treating Patients With Recurrent High Grade Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy - This study has been completed (Current: 23 Nov 2006) - SU5416
• O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - O6-benzylguanine,polifeprosan 20 with carmustine implant
• Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - acridine carboxamide
• Carmustine Plus O6-Benzylguanine in Treating Patients With Recurrent or Progressive Glioma - This study has been completed (Current: 23 Nov 2006) - carmustine,O6-benzylguanine
• Fenretinide in Treating Patients With Recurrent Malignant Glioma - This study has been completed (Current: 23 Nov 2006) - fenretinide
• Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor - This study has been completed (Current: 23 Nov 2006) - temozolomide,thalidomide
• Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,temozolomide
• Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - glufosfamide
• NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - interleukin-4 PE38KDEL cytotoxin
• Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme - This study has been completed (Current: 23 Nov 2006) - carboplatin,temozolomide
• Taurolidine in Treating Patients With Recurrent or Progressive Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - taurolidine
• SarCNU in Treating Patients With Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - SarCNU
• Melphalan in Patients With Neoplastic Meningitis - This study is no longer recruiting patients (Current: 23 Nov 2006) - melphalan
• Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy - This study has been completed (Current: 23 Nov 2006)
• A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006) - Dronabinol
• Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms - This study is no longer recruiting patients (Current: 23 Nov 2006) - carmustine,mercaptopurine,streptozocin
• Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors - This study has been completed (Current: 23 Nov 2006)
• An Immunotherapy Vaccine Against Grade IV Brain Tumors - This study has been suspended (Current: 23 Nov 2006)
• XERECEPT (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - XERECEPT (corticorelin acetate)
• XERECEPT (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema - This study is currently recruiting patients (Current: 23 Nov 2006) - XERECEPT (corticorelin acetate)
• An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies - This study is currently recruiting patients (Current: 23 Nov 2006) - XERECEPT (corticorelin acetate)
• Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma. - This study has been completed (Current: 23 Nov 2006) - 131I-TM-601
• Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation Necrosis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Evaluation of Factors in Human Brain Tumors - This study has been completed (Current: 23 Nov 2006)
• Gene Therapy for the Treatment of Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - Cytovene (Ganciclovir Sodium)
• 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - 131I-TM-601
• A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects - This study is currently recruiting patients (Current: 23 Nov 2006)
• Comparison of Educational Services and Outcomes for Patients Treated for Childhood Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Serial CT Scans in Fractionated Stereotactic Radiotherapy - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors - This study has been suspended (Current: 23 Nov 2006) - Everolimus
• The Roles of Tissue Factor in Malignant Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006)
• Neurosurgical Use of Interstitial Laser Therapy (ILT) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Busulfan in Treating Children and Adolescents With Refractory CNS Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - busulfan
• Magnetic Resonance Imaging Using Ferumoxytol in Patients With Primary Brain Cancer or Brain Metastases From Lung or Breast Cancer - This study has been suspended (Current: 23 Nov 2006) - ferumoxytol
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors - This study has been suspended (Current: 23 Nov 2006) - astatine At 211 monoclonal antibody 81C6
• Temozolomide in Treating Patients With Progressive Low-Grade Glioma - This study has been completed (Current: 23 Nov 2006) - temozolomide
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - iodine I 131 monoclonal antibody 81C6
• Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - autologous lymphocytes,autologous tumor cell vaccine,interleukin-2,monoclonal antibody OKT3,sargramostim
• Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,pyrazoloacridine
• Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - irinotecan,temozolomide
• Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - rebeccamycin analogue
• Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma - This study has been completed (Current: 23 Nov 2006) - imatinib mesylate
• Diagnostic Study In Patients Receiving Treatment For Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - gadopentetate dimeglumine
• CCI-779 in Treating Patients With Malignant Glioma - This study has been completed (Current: 23 Nov 2006) - temsirolimus
• Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - EGFR antisense DNA,keyhole limpet hemocyanin,sargramostim
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,filgrastim,temozolomide,thiotepa
• Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - gefitinib
• Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - methylphenidate
• CC-5013 in Treating Patients With Recurrent Glioma - This study has been completed (Current: 23 Nov 2006) - CC-5013
• Imatinib Mesylate in Treating Patients With Gliomas - This study is no longer recruiting patients (Current: 23 Nov 2006) - imatinib mesylate
• Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma - This study has been completed (Current: 23 Nov 2006) - erlotinib
• Ixabepilone in Treating Patients With Recurrent Glioma - This study has been completed (Current: 23 Nov 2006) - ixabepilone
• Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - celecoxib,cyclophosphamide,etoposide,thalidomide
• LY317615 in Treating Patients With Recurrent Gliomas - This study is no longer recruiting patients (Current: 23 Nov 2006) - enzastaurin
• Cilengitide in Treating Children With Refractory Primary Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - cilengitide
• Talampanel in Treating Patients With Recurrent High-Grade Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - talampanel
• CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas - This study has been completed (Current: 23 Nov 2006) - CC-8490
• Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - erlotinib hydrochloride,temozolomide
• Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - irinotecan hydrochloride,temozolomide,vincristine
• Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - acetylcysteine,carboplatin,cyclophosphamide,etoposide phosphate,filgrastim,mannitol,sodium thiosulfate
• Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery - This study is currently recruiting patients (Current: 23 Nov 2006) - arsenic trioxide,temozolomide
• A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors - This study has been completed (Current: 23 Nov 2006)
• Radiation Therapy Following Surgery to Remove Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Study of Temozolomide in the Treatment of Brain Metastasis From Non-Small-Cell Lung Cancer (Study P02143)(COMPLETED) - This study has been completed (Current: 23 Nov 2006) - temozolomide
• Study of Vioxx and Radiation Therapy for Brainstem Glioma - This study has been terminated (Current: 23 Nov 2006) - Vioxx
• Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas - This study has been terminated (Current: 23 Nov 2006) - DTI-015
• Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - 111In-DAC
• Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247AM3) - This study is currently recruiting patients (Current: 23 Nov 2006) - Temozolomide
• Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Study of Tomotherapy in Patients With Benign Brain Tumour - This study is currently recruiting patients (Current: 23 Nov 2006)
• Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain Metastases - This study is currently recruiting patients (Current: 23 Nov 2006)
• 18F-FDG Positron Emission Tomography in Oncology - This study is currently recruiting patients (Current: 23 Nov 2006)
• Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Iressa (Gefitinib) , cytostatic drug, an EGFR-TK inhibitor, p.o 250 mg a day
• Treatment of Brain Metastases From Non-Small Cell Lung Cancer With Brain Radiation and Pemetrexed - This study is currently recruiting patients (Current: 23 Nov 2006) - Pemetrexed
• Radiotherapy - Cerebrovascular Reactivity (RT-CVR Study) - This study is currently recruiting patients (Current: 23 Nov 2006)
• A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Brain Metastases Due to Non-Squamous NSCLC - This study is currently recruiting patients (Current: 23 Nov 2006) - Bevacizumab
• Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases - This study is currently recruiting patients (Current: 23 Nov 2006) - MPC-6827
• PET Scan of Brain Metabolism in Relation to Age and Disease - This study has been completed (Current: 23 Nov 2006) - 15 O Water
• Brain Neoplasms, Leukemia and Petrochemical Exposures - This study is currently recruiting patients (Current: 23 Nov 2006)
• A Trial Comparing Radiosurgery With Surgery for Solitary Brain Metastases - This study is currently recruiting patients (Current: 23 Nov 2006)
• Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury - This study is currently recruiting patients (Current: 23 Nov 2006)
• Docetaxel in Treating Children With Recurrent Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - docetaxel,filgrastim
• Vinorelbine in Treating Children With Recurrent or Refractory Cancers - This study has been completed (Current: 23 Nov 2006) - vinorelbine
• O6-Benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - carmustine,O6-benzylguanine
• Surgery Plus Radiation Therapy With and Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,cyclophosphamide,etoposide,vincristine
• SU5416 in Treating Children With Recurrent or Progressive Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - SU5416
• Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - leucovorin calcium,mechlorethamine,methotrexate,prednisone,procarbazine,vincristine
• Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Neuroectodermal Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,cisplatin,cyclophosphamide,filgrastim,vincristine
• Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,cyclophosphamide,filgrastim,thiotepa,vincristine
• Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children - This study has been completed (Current: 23 Nov 2006)
• Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors - This study has been completed (Current: 23 Nov 2006) - Phenylbutyrate
• Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - Mesna,Cisplatin,Vincristine,Etoposide,Mafosfamide,Dexamethasone,Morphine,Cyclophosphamide
• Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients - This study is currently recruiting patients (Current: 23 Nov 2006) - dalteparin
• F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response - This study is currently recruiting patients (Current: 23 Nov 2006)
• Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma - Could not be determined (Current: 23 Nov 2006)
• Collecting and Banking Pediatric Brain Tumor Research Specimens - This study is currently recruiting patients (Current: 23 Nov 2006)
• Evaluation of Kidney Function in Children With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• A Case-Referent Study of Brain Tumors in Adults - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,temozolomide
• Multihance at 3 Tesla in Brain Tumors - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Multihance
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,cisplatin,cyclophosphamide,etoposide,filgrastim,thiotepa,vincristine
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,cisplatin,cyclophosphamide,etoposide,filgrastim,leucovorin calcium,methotrexate,temozolomide,thiotepa,vincristine
• Irinotecan in Treating Children With Refractory Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - irinotecan hydrochloride
• DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas - This study has been completed (Current: 23 Nov 2006) - exatecan mesylate,filgrastim
• Chemotherapy and Radiation Therapy in Treating Infants With Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,cyclophosphamide,etoposide,mafosfamide,vincristine
• Topotecan in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment - This study has been completed (Current: 23 Nov 2006) - topotecan hydrochloride
• Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - temozolomide
• Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma - This study has been completed (Current: 23 Nov 2006) - cisplatin,cyclophosphamide,etoposide,filgrastim,methotrexate,vincristine
• SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - lonafarnib
• Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - modafinil
• Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors - This study has been completed (Current: 23 Nov 2006) - O6-benzylguanine,filgrastim,temozolomide
• Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,etoposide,filgrastim
• FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia - This study has been completed (Current: 23 Nov 2006) - FR901228
• Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - ixabepilone
• Donepezil or EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006) - EGb761,donepezil hydrochloride
• Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - tipifarnib
• VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - VNP40101M
• Serum DNA Analysis: Potential Application for Diagnosis and Prognosis in Brain Cancer. - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,cisplatin,cyclophosphamide,methotrexate,vincristine
• Comparing 2 Forms of Head Immobilization for Stereotactic Radiotherapy - This study is currently recruiting patients (Current: 23 Nov 2006)
• Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation - This study is currently recruiting patients (Current: 23 Nov 2006) - itraconazole
• Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - bevacizumab,fludeoxyglucose F 18,irinotecan hydrochloride
• Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors - This study has been completed (Current: 23 Nov 2006) - cyclophosphamide,melphalan,sargramostim
• Chemotherapy in Treating Patients With Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - carmustine,topotecan
• Biological Therapy in Treating Patients With Primary or Advanced Glioma - This study has been suspended (Current: 23 Nov 2006) - interleukin-2,lymphokine-activated killer cells
• Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - carmustine,polifeprosan 20 with carmustine implant
• Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - antineoplaston A10,antineoplaston AS2-1
• Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - antineoplaston A10,antineoplaston AS2-1
• Antineoplaston Therapy in Treating Patients With Meningioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - antineoplaston A10,antineoplaston AS2-1
• Hydroxyurea in Treating Patients With Unresectable Benign Meningioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - hydroxyurea
• Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas - This study is no longer recruiting patients (Current: 23 Nov 2006) - carmustine,lomustine,porfimer sodium,procarbazine
• Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - iodine I 131 monoclonal antibody TNT-1/B
• Carmustine in Treating Patients With Recurrent Malignant Glioma - This study has been completed (Current: 23 Nov 2006) - carmustine
• COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - COL-3
• Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - carmustine,efaproxiral
• Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma - This study has been completed (Current: 23 Nov 2006) - tipifarnib
• Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma - This study has been completed (Current: 23 Nov 2006) - irinotecan,temozolomide
• EMD 121974 in Treating Patients With Progressive or Recurrent Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - EMD 121974
• Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - hydroxyurea
• Immunotoxin Therapy in Treating Patients With Malignant Glioma - This study has been completed (Current: 23 Nov 2006) - interleukin-13 PE38QQR immunotoxin
• Temozolomide and O6-Benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - O6-benzylguanine,temozolomide
• Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme - This study has been suspended (Current: 23 Nov 2006) - carmustine in ethanol
• Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors - This study has been completed (Current: 23 Nov 2006) - irofulven
• Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - thalidomide,topotecan hydrochloride
• Karenitecin in Treating Patients With Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - karenitecin
• CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - CCI-779
• ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse - This study is no longer recruiting patients (Current: 23 Nov 2006) - gefitinib
• Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - atrasentan
• Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma - This study has been completed (Current: 23 Nov 2006) - gefitinib,temozolomide
• Gene Therapy in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme - This study has been suspended (Current: 23 Nov 2006) - BG00001
• Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - interleukin-13 PE38QQR immunotoxin
• Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy - This study is no longer recruiting patients (Current: 23 Nov 2006) - irinotecan,thalidomide
• Brachytherapy in Treating Patients With Recurrent Malignant Glioma - This study has been completed (Current: 23 Nov 2006) - iodine I 125
• Imatinib Mesylate in Treating Patients With Recurrent Meningioma - This study has been completed (Current: 23 Nov 2006) - imatinib mesylate
• Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor - This study has been suspended (Current: 23 Nov 2006) - imatinib mesylate
• Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - poly ICLC
• TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma - This study has been suspended (Current: 23 Nov 2006) - TGFa-PE38 immunotoxin
• Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - fenretinide
• Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006) - alanosine
• Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - carmustine,erlotinib hydrochloride,temozolomide
• Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma - This study has been completed (Current: 23 Nov 2006) - gimatecan
• Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006) - lapatinib
• AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - AEE788,everolimus
• Photodynamic Therapy Using Porfimer Sodium in Treating Patients Who Are Undergoing Surgery for Recurrent Malignant Astrocytoma - This study is currently recruiting patients (Current: 23 Nov 2006) - porfimer sodium
• Cilengitide in Treating Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - cilengitide
• Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers - This study is currently recruiting patients (Current: 23 Nov 2006)
• A Phase I/II Study of the Photon Radiosurgery System - This study is currently recruiting patients (Current: 23 Nov 2006)
• MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Phenylbutyrate in Treating Children With Progressive or Recurrent Cancer of the Central Nervous System - This study is no longer recruiting patients (Current: 23 Nov 2006) - phenylbutyrate
• Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas - This study is no longer recruiting patients (Current: 23 Nov 2006) - flavopiridol
• Anaesthesia for Supratentorial Tumor Resection - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Comparison of two anesthetics protocol,propofol-remifentanil,sufentanil-sevoflurane
• Penclomedine in Treating Patients With Solid Tumors or Lymphoma - This study has been completed (Current: 23 Nov 2006) - penclomedine
• Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,filgrastim,thiotepa
• Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - amifostine,carboplatin,etoposide,filgrastim,ifosfamide
• Decitabine in Treating Patients With Melanoma or Other Advanced Cancer - This study has been completed (Current: 23 Nov 2006) - decitabine
• Combination Chemotherapy in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - fluorouracil,leucovorin calcium,topotecan
• Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - interferon alfa,interleukin-12
• Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors - This study has been completed (Current: 23 Nov 2006) - irinotecan,LY231514
• Combination Chemotherapy in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - fluorouracil,leucovorin calcium,SCH 66336
• Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - amifostine,carboplatin,cyclophosphamide,sargramostim
• Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Evaluation of Patients With Thyroid Disorders - This study is currently recruiting patients (Current: 23 Nov 2006)
• Genetic Investigation of Pediatric Tumors of the Pituitary Gland - This study is currently recruiting patients (Current: 23 Nov 2006)
• Sandostatin LAR Depot Vs. Surgery for Treating Acromegaly - This study has been completed (Current: 23 Nov 2006)
• The Treatment and Natural History of Acromegaly - This study is currently recruiting patients (Current: 23 Nov 2006)
• Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors - This study has been completed (Current: 23 Nov 2006)
• Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006) - amifostine,cisplatin,cyclophosphamide,filgrastim,vincristine
• Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy - This study is currently recruiting patients (Current: 23 Nov 2006) - antineoplaston A10,antineoplaston AS2-1
• Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006) - gadolinium texaphyrin
• Carmustine Implants in Treating Patients With Brain Metastases - This study has been completed (Current: 23 Nov 2006) - polifeprosan 20 with carmustine implant
• Radiation Therapy Followed by Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Malignant Melanoma - This study has been completed (Current: 23 Nov 2006)
• Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006) - RSR13
• Temozolomide in Treating Patients With Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006) - temozolomide
• Stereotactic Radiation Therapy in Treating Patients With Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor - This study is currently recruiting patients (Current: 23 Nov 2006) - cisplatin,cyclophosphamide,etoposide,vincristine
• Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm - This study is no longer recruiting patients (Current: 23 Nov 2006) - carmustine in ethanol
• Genetic Study of Brain Tumors in Young Children - This study has been completed (Current: 23 Nov 2006)
• Temozolomide in Treating Patients With Solid Tumors That Have Spread to the Brain - This study is no longer recruiting patients (Current: 23 Nov 2006) - temozolomide
• Lobradimil and Carboplatin in Treating Children With Brain Tumors - This study has been completed (Current: 23 Nov 2006) - carboplatin,lobradimil
• Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain - This study is no longer recruiting patients (Current: 23 Nov 2006) - temozolomide
• Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Radiation Therapy With or Without Temozolomide in Treating Patients With Non-Small Cell Lung Cancer That is Metastatic to the Brain - This study is no longer recruiting patients (Current: 23 Nov 2006) - temozolomide
• Melatonin and Radiation Therapy in Treating Patients With Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006) - melatonin
• Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006) - thalidomide
• Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain - This study is no longer recruiting patients (Current: 23 Nov 2006) - boronophenylalanine-fructose complex
• Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006) - oxaliplatin
• Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - temozolomide,thalidomide
• Predictive Value of Dynamic Contrast Enhancement MRI on a Cerebral Tumor Response to Gamma Knife Treatment - This study is currently recruiting patients (Current: 23 Nov 2006)
• Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - Carboplatin,Thalomid
• Evaluate the Efficacy and Safety of Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• 2DG Study: 2-Deoxyglucose (2DG) and Stereotactic Radiosurgery (SRS) Protocol for Treatment of Intracranial Metastases - This study is currently recruiting patients (Current: 23 Nov 2006) - 2-deoxyglucose (2DG)
• Quality of Life in Patients Who Have Undergone Previous Treatment for Primitive Neuroectodermal Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• A Randomized Study of Sulindac in Oral Premalignant Lesions - This study is currently recruiting patients (Current: 23 Nov 2006) - sulindac
• Velcade Plus Chemoradiation for Central Nervous System (CNS), Head and Neck, and Cervical Cancer Patients - This study is currently recruiting patients (Current: 23 Nov 2006) - Velcade (bortezomib)
• Brain Tumor Caregivers - This study is no longer recruiting patients (Current: 23 Nov 2006)
• QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC - This study is currently recruiting patients (Current: 23 Nov 2006) - Temozolomide,Erlotinib
• Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - carmustine
• Radiation Therapy in Treating Patients With Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carmustine,mitolactol
• Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma - This study has been completed (Current: 23 Nov 2006) - lomustine,procarbazine,vincristine
• Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma - This study has been completed (Current: 23 Nov 2006) - cisplatin,cyclophosphamide,filgrastim,lomustine,mesna,vincristine
• Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,vincristine
• Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - lomustine,procarbazine,thiotepa,vincristine
• Biological Therapy in Treating Patients With Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - autologous tumor cell vaccine,cyclophosphamide,sargramostim
• Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - temozolomide
• Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - motexafin gadolinium
• Gadolinium Texaphyrin With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas - This study has been completed (Current: 23 Nov 2006) - gadolinium texaphyrin
• Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme - This study has been completed (Current: 23 Nov 2006) - temozolomide
• Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,cyclophosphamide,etoposide,filgrastim,vincristine
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Astrocytoma - This study has been completed (Current: 23 Nov 2006) - carmustine,cisplatin,etoposide
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma - This study has been completed (Current: 23 Nov 2006) - cyclosporine,etoposide,vincristine
• Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - temozolomide
• Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - penicillamine,pyridoxine
• Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - etoposide,vincristine
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - carmustine,cisplatin,etoposide
• Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006) - irinotecan,temozolomide
• Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - suramin
• Carboxyamidotriazole Plus Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboxyamidotriazole
• Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - prinomastat,temozolomide
• Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma - This study has been completed (Current: 23 Nov 2006) - dexamethasone
• Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors - This study has been completed (Current: 23 Nov 2006)
• Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - bispecific antibody MDX447,bispecific antibody MDX447/lymphokine-activated killer cells,lymphokine-activated killer cells
• Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - nitrocamptothecin
• Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - This study has been completed (Current: 23 Nov 2006) - temozolomide
• Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme - This study has been completed (Current: 23 Nov 2006) - tamoxifen
• Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - motexafin gadolinium
• Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - hyperbaric oxygen
• Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,irinotecan
• ZD 1839 in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - gefitinib
• Radiation Therapy in Treating Patients With Glioblastoma - This study has been completed (Current: 23 Nov 2006) - hydroxyurea,pentoxifylline
• Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma - This study has been completed (Current: 23 Nov 2006) - cladribine
• Phase II Study of Motexafin Gadolinium and Cranial Irradiation in Patients With Newly Diagnosed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - motexafin gadolinium
• Carmustine and O6-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - chemosensitization/potentiation,carmustine,O6-benzylguanine
• Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors - This study has been completed (Current: 23 Nov 2006) - cisplatin,doxorubicin,tamoxifen
• The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006) - IL13-PE38QQR,prolifespan 20 with carmustine implant (GLIADEL® Wafer)
• IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - IL13-PE38QQR,Temozolomide with radiation therapy
• Genetic Analysis of Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• The Role of Gene Changes in Brain Tumor Formation and Growth - This study has been completed (Current: 23 Nov 2006)
• Investigating Endothelial Precursor Cells (EPCs) - This study has been completed (Current: 23 Nov 2006)
• Light Scattering Spectroscopy to Determine Brain Tumors - This study has been completed (Current: 23 Nov 2006)
• Study of Individuals and Families at High Risk for Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Analysis of Brain Metastasis in Patients With Lung Cancer - This study has been completed (Current: 23 Nov 2006)
• Topotecan in Treating Patients With Refractory or Progressive Primary Malignant Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - topotecan hydrochloride
• The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer - This study has been terminated (Current: 23 Nov 2006) - Methotrexate,Leucovorin calcium,Zidovudine,Dexamethasone
• Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma - This study has been completed (Current: 23 Nov 2006) - Filgrastim,Vincristine sulfate,Doxorubicin hydrochloride,Cyclophosphamide,Cytarabine,Dexamethasone
• Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme - This study has been suspended (Current: 23 Nov 2006) - temozolomide and R115777
• Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006) - IL13-PE38QQR
• Evaluation, Treatment, and Natural History of Children With Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Monoclonal Antibody Therapy in Treating Patients With Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006) - monoclonal antibody Me1-14 F(ab')2
• Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - cytarabine (liposomal)
• Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer - This study has been completed (Current: 23 Nov 2006) - R115777,R115777/trastuzumab,trastuzumab
• Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer - This study has been completed (Current: 23 Nov 2006) - G207, an oncolytic virus
• Efficacy of Distant Healing in Glioblastoma Treatment - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas - This study has been suspended (Current: 23 Nov 2006)
• Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme - This study has been terminated (Current: 23 Nov 2006) - Temozolomide and SCH66336
• Evaluation and Treatment of Neurosurgical Disorders - This study is currently recruiting patients (Current: 23 Nov 2006)
• Phase I Study of Depsipeptide in Children With Cancer - This study has been completed (Current: 23 Nov 2006) - Depsipeptide
• Study of Therapy With TransMID Compared to Best Standard of Care in Patients With Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006) - TransMID™
• Comparison of TransMID Vs Standard Treatment of Cancerous Brain Tumors - This study has been completed (Current: 23 Nov 2006) - TransMID
• Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor) - This study is no longer recruiting patients (Current: 23 Nov 2006) - EMD 121974
• Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma - This study is currently recruiting patients (Current: 23 Nov 2006) - boronophenylalanine-based BNCT
• Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma - This study is currently recruiting patients (Current: 23 Nov 2006) - Imatinib mesylate; hydroxyurea
• G207 Followed by Radiation Therapy in Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - G207
• A-Protein Levels in Adult and Pediatric Brain Tumor Patients - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Open-Label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors) - This study is currently recruiting patients (Current: 23 Nov 2006) - imatinib mesylate
• Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - vinblastine sulphate injection
• Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours - This study is currently recruiting patients (Current: 23 Nov 2006)
• A Phase II Exploratory, Multicentre, Open-Label, Non-Comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme - This study has been completed (Current: 23 Nov 2006) - Gefitinib
• Cognitive Rehabilitation of Glioma Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
• Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma - This study is currently recruiting patients (Current: 23 Nov 2006) - Erlotinib, Tarceva, OSI-774
• Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development - This study is currently recruiting patients (Current: 23 Nov 2006)
• Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas - This study is currently recruiting patients (Current: 23 Nov 2006) - Irinotecan HCL
• Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma - This study is currently recruiting patients (Current: 23 Nov 2006) - Temozolomide (Temodar)
• Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly - This study is currently recruiting patients (Current: 23 Nov 2006) - Octreotide acetate and cabergoline
• Radiation Boost for Newly Diagnosed Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006) - temozolomide
• Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment of Brain Metastases Resulting From Non-Small Lung Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - HYCAMTIN, oral capsules
• Diagnostic Imaging in Children With Primary Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - motexafin gadolinium
• Vaccine Therapy in Treating Patients With Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - therapeutic autologous dendritic cells
• Analysis of Brain Metastasis in Patients With Breast Cancer, With and Without Over-Expression of HER-2 - This study has been completed (Current: 23 Nov 2006)
• Genetic Study of Late-Occurring Complications in Childhood Cancer Survivors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - benzoporphyrin derivative monoacid ring A
• Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer - This study has been suspended (Current: 23 Nov 2006) - iodine I 131 monoclonal antibody 3F8
• Antineoplaston Therapy in Treating Patients With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - antineoplaston A10,antineoplaston AS2-1
• Antineoplaston Therapy in Treating Patients With Brain Stem Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - antineoplaston A10,antineoplaston AS2-1
• Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma - This study is currently recruiting patients (Current: 23 Nov 2006) - antineoplaston A10,antineoplaston AS2-1
• Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma - This study is currently recruiting patients (Current: 23 Nov 2006) - antineoplaston A10,antineoplaston AS2-1
• Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006) - antineoplaston A10,antineoplaston AS2-1
• Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - antineoplaston A10,antineoplaston AS2-1
• Antineoplaston Therapy in Treating Patients With Residual or Recurrent Anaplastic Astrocytoma - This study is currently recruiting patients (Current: 23 Nov 2006) - antineoplaston A10,antineoplaston AS2-1
• Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma - This study is currently recruiting patients (Current: 23 Nov 2006) - O6-benzylguanine,carmustine,filgrastim,sargramostim,temozolomide,therapeutic autologous lymphocytes
• Phosphorus 32 in Treating Patients With Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006) - phosphorus P32
• Bortezomib in Treating Patients With Recurrent Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - bortezomib
• Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - carmustine,cisplatin,cyclophosphamide,etoposide,filgrastim,thiotepa
• Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - cyclophosphamide,filgrastim,sargramostim,thiotepa
• Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboxyamidotriazole,paclitaxel
• Temozolomide and O6-Benzylguanine in Treating Children With Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - O6-benzylguanine,temozolomide
• MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - MS-275
• Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure - This study has been completed (Current: 23 Nov 2006) - imatinib mesylate
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction - This study is no longer recruiting patients (Current: 23 Nov 2006) - erlotinib
• Screening Patients With Central Nervous System Tumors for Participation in National Cancer Institute Clinical Trials - This study is currently recruiting patients (Current: 23 Nov 2006)
• Sirolimus in Treating Patients With Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006) - sirolimus
• Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - yttrium Y 90-DOTA-tyr3-octreotide
• Thalidomide and Docetaxel in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - docetaxel,thalidomide
• Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - lomustine,procarbazine hydrochloride,temozolomide,vincristine
• PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent High-Grade Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006) - PEG-interferon alfa-2b,thalidomide
• Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006) - cintredekin besudotox
• Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006) - erlotinib hydrochloride
• Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment - This study is currently recruiting patients (Current: 23 Nov 2006) - cyproheptadine,megestrol
• BCX-1777 in Treating Patients With Refractory Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - BCX-1777
• Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Sodium Thiosulfate in Treating Patients With High-Grade Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,cyclophosphamide,etoposide,etoposide phosphate,filgrastim,sodium thiosulfate
• Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - procarbazine hydrochloride,thalidomide
• Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006) - lonafarnib,temozolomide
• FR901228 in Treating Patients With Recurrent High-Grade Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006) - FR901228
• Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - everolimus,gefitinib
• Intratumoral Transferrin-CRM107 Compared With Best Standard Chemotherapy in Treating Patients With Progressive and/or Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,carmustine,cisplatin,lomustine,nimustine,procarbazine hydrochloride,temozolomide,transferrin-CRM107,vincristine
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - iodine I 131 monoclonal antibody 8H9
• Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - sorafenib
• Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - lenalidomide
• Lapatinib in Treating Patients Who Are Undergoing Surgery for Recurrent Progressive Glioblastoma Multiforme or Gliosarcoma - This study is currently recruiting patients (Current: 23 Nov 2006) - lapatinib
• Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - valproic acid
• Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - erlotinib hydrochloride,temsirolimus
• Tamoxifen and Bortezomib in Treating Patients With Recurrent Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006) - bortezomib,tamoxifen citrate
• Enzastaurin in Treating Patients With Recurrent Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006) - enzastaurin hydrochloride
• Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006) - cilengitide
• Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006) - iodine I 131 monoclonal antibody TNT-1/B
• Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006) - vorinostat
• Melphalan and Mannitol in Treating Patients With Central Nervous System Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - mannitol,melphalan
• Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006) - bevacizumab,irinotecan hydrochloride
• Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006) - temozolomide,vorinostat
• O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - O6-benzylguanine,temozolomide
• Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006) - 3'-deoxy-3'-[18F]fluorothymidine
• Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases - This study is currently recruiting patients (Current: 23 Nov 2006) - pemetrexed disodium
• Bevacizumab in Treating Patients With Recurrent Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - bevacizumab
• GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - gp96 heat shock protein-peptide complex
• ZD6474 in Treating Patients With Recurrent or Progressive Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006) - ZD6474
• Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - zoledronate
• Combination Chemotherapy and Blood-Brain Barrier Disruption Followed By Sodium Thiosulfate in Treating Patients With Anaplastic Oligodendroglioma or Oligoastrocytoma - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,etoposide phosphate,mannitol,melphalan,sodium thiosulfate
• Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,talabostat mesylate,temozolomide
• AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006) - AZD2171
• AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - AZD2171
• Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma - This study is currently recruiting patients (Current: 23 Nov 2006) - sorafenib,temsirolimus
• Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma - This study is currently recruiting patients (Current: 23 Nov 2006) - erlotinib hydrochloride,sorafenib tosylate,temsirolimus,tipifarnib
• Bevacizumab in Treating Patients With Recurrent or Progressive Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - bevacizumab
• RTA 744 in Treating Patients With Recurrent or Refractory Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Mixed Oligoastrocytoma, Glioblastoma Multiforme, or Gliosarcoma - This study is currently recruiting patients (Current: 23 Nov 2006) - topoisomerase II inhibitor RTA 744
• Vatalanib in Treating Patients With Recurrent or Progressive Meningioma - This study is currently recruiting patients (Current: 23 Nov 2006) - vatalanib
• ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - ATN-161,carboplatin
• MRI in Patients Receiving Bevacizumab and Irinotecan for Recurrent Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - bevacizumab,irinotecan hydrochloride
• Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - imatinib mesylate,temozolomide
• Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma - This study is currently recruiting patients (Current: 23 Nov 2006) - hydroxyurea,imatinib mesylate
• Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Treating Young Patients With Relapsed or Progressive Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - celecoxib,cyclophosphamide,etoposide,thalidomide
• Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - erlotinib hydrochloride
• Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - cisplatin,temozolomide
• Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006) - O6-benzylguanine,polifeprosan 20 with carmustine implant
• Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma - This study is currently recruiting patients (Current: 23 Nov 2006) - ispinesib
• VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide - This study is currently recruiting patients (Current: 23 Nov 2006) - VEGF Trap
• Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers - This study is currently recruiting patients (Current: 23 Nov 2006)
• Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - tandutinib
• Everolimus and Temozolomide in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006) - everolimus,temozolomide
• Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - erlotinib hydrochloride
• Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - hydroxyurea,imatinib mesylate,vatalanib
• Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006) - MV-CEA
• Bevacizumab and Irinotecan in Treating Patients With Recurrent High-Grade Malignant Glioma That Progressed on Bevacizumab Alone - This study is currently recruiting patients (Current: 23 Nov 2006) - bevacizumab,irinotecan hydrochloride
• Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006) - imatinib mesylate
• Side Effects of Radiation Therapy in Young Patients With CNS Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)

Drugs used in Clinical Trials for Brain cancer

The format for each of the following is:

• The drug,
• followed by the name of the trial,
• followed by whether the trial is recruiting patients,
  - The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
  - Note**: Please follow the link to determine the current trial status.

ClinicalTrials.gov has listed the following drugs in trials for Brain cancer:

• 111In-DAC - Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• 131I-TM-601 - 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• 131I-TM-601 - Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma. - This study has been completed (Current: 23 Nov 2006)
• 15 O Water - PET Scan of Brain Metabolism in Relation to Age and Disease - This study has been completed (Current: 23 Nov 2006)
• 2-deoxyglucose (2DG) - 2DG Study: 2-Deoxyglucose (2DG) and Stereotactic Radiosurgery (SRS) Protocol for Treatment of Intracranial Metastases - This study is currently recruiting patients (Current: 23 Nov 2006)
• 3'-deoxy-3'-[18F]fluorothymidine - Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006)
• 5-aminolevulinic acid - Fluorescence-Guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid - This study has been completed (Current: 23 Nov 2006)
• AEE788 - AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• ATN-161 - ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• AZD2171 - AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006)
• AZD2171 - AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Acetylcysteine - Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Acridine Carboxamide - Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adenovirus P53 - Gene Therapy in Treating Patients With Recurrent Malignant Gliomas - This study has been completed (Current: 23 Nov 2006)
• Administration of Hypertonic Solution 7.5% vs Mannitol 20% - Hypertonic Saline 75% Vs Mannitol 20% - This study is currently recruiting patients (Current: 23 Nov 2006)
• Alanosine - Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006)
• Amifostine - Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Amifostine - Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Amifostine - Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Amifostine - Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Antineoplaston A10 - Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston A10 - Antineoplaston Therapy in Treating Patients With Brain Stem Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston A10 - Antineoplaston Therapy in Treating Patients With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston A10 - Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Antineoplaston A10 - Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Antineoplaston A10 - Antineoplaston Therapy in Treating Patients With Meningioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Antineoplaston A10 - Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston A10 - Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston A10 - Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston A10 - Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston A10 - Antineoplaston Therapy in Treating Patients With Residual or Recurrent Anaplastic Astrocytoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston As2-1 - Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston As2-1 - Antineoplaston Therapy in Treating Patients With Brain Stem Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston As2-1 - Antineoplaston Therapy in Treating Patients With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston As2-1 - Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Antineoplaston As2-1 - Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Antineoplaston As2-1 - Antineoplaston Therapy in Treating Patients With Meningioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Antineoplaston As2-1 - Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston As2-1 - Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston As2-1 - Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston As2-1 - Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston As2-1 - Antineoplaston Therapy in Treating Patients With Residual or Recurrent Anaplastic Astrocytoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Arsenic Trioxide - Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery - This study is currently recruiting patients (Current: 23 Nov 2006)
• Astatine At 211 Monoclonal Antibody 81C6 - Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors - This study has been suspended (Current: 23 Nov 2006)
• Atrasentan - Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Autologous Lymphocytes - Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Autologous Lymphocytes - Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Autologous Tumor Cell Vaccine - Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Autologous Tumor Cell Vaccine - Biological Therapy in Treating Patients With Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Autologous Tumor Cell Vaccine - Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• BCX-1777 - BCX-1777 in Treating Patients With Refractory Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• BG00001 - Gene Therapy in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme - This study has been suspended (Current: 23 Nov 2006)
• Benzoporphyrin Derivative Monoacid Ring A - Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Brain Metastases Due to Non-Squamous NSCLC - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Bevacizumab and Irinotecan in Treating Patients With Recurrent High-Grade Malignant Glioma That Progressed on Bevacizumab Alone - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Bevacizumab in Treating Patients With Recurrent Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Bevacizumab in Treating Patients With Recurrent or Progressive Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - MRI in Patients Receiving Bevacizumab and Irinotecan for Recurrent Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bispecific Antibody Mdx447/Lymphokine-Activated Killer Cells - Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bispecific Antibody Mdx447 - Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bone Marrow Ablation With Stem Cell Support - Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bone Marrow Ablation With Stem Cell Support - High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Boronophenylalanine-Based Bnct - Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Boronophenylalanine-Fructose Complex - Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bortezomib - Bortezomib in Treating Patients With Recurrent Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bortezomib - Tamoxifen and Bortezomib in Treating Patients With Recurrent Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006)
• Busulfan - Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Busulfan - Busulfan in Treating Children and Adolescents With Refractory CNS Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• CC-5013 - CC-5013 in Treating Patients With Recurrent Glioma - This study has been completed (Current: 23 Nov 2006)
• CC-8490 - CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas - This study has been completed (Current: 23 Nov 2006)
• CCI-779 - CCI-779 in Treating Patients With Advanced Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• CCI-779 - CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• COL-3 - COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Calcitriol - Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases - This study is currently recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Carboplatin in Patients With Progressive Gliomas - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Sodium Thiosulfate in Treating Patients With High-Grade Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Neuroectodermal Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Combination Chemotherapy and Blood-Brain Barrier Disruption Followed By Sodium Thiosulfate in Treating Patients With Anaplastic Oligodendroglioma or Oligoastrocytoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Intratumoral Transferrin-CRM107 Compared With Best Standard Chemotherapy in Treating Patients With Progressive and/or Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Lobradimil and Carboplatin in Treating Children With Brain Tumors - This study has been completed (Current: 23 Nov 2006)
• Carboplatin - Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Surgery Plus Radiation Therapy With and Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Carboplatin - Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme - This study has been completed (Current: 23 Nov 2006)
• Carboplatin - Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Carboxyamidotriazole - Carboxyamidotriazole Plus Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carboxyamidotriazole - Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine In Ethanol - Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine In Ethanol - Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme - This study has been suspended (Current: 23 Nov 2006)
• Carmustine - Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine - Carmustine Plus O6-Benzylguanine in Treating Patients With Recurrent or Progressive Glioma - This study has been completed (Current: 23 Nov 2006)
• Carmustine - Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas - This study has been completed (Current: 23 Nov 2006)
• Carmustine - Carmustine and O6-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine - Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine - Carmustine in Treating Patients With Recurrent Malignant Glioma - This study has been completed (Current: 23 Nov 2006)
• Carmustine - Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Carmustine - Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine - Chemotherapy in Treating Patients With Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine - Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Astrocytoma - This study has been completed (Current: 23 Nov 2006)
• Carmustine - Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine - Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Carmustine - Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine - Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Carmustine - Intratumoral Transferrin-CRM107 Compared With Best Standard Chemotherapy in Treating Patients With Progressive and/or Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006)
• Carmustine - Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine - O6-Benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine - Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine - Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine - Radiation Therapy in Treating Patients With Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine - Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine - Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Carmustine - Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Celecoxib - Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Treating Young Patients With Relapsed or Progressive Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Celecoxib - Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Chemoprotection - Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Chemosensitization/Potentiation - Carmustine and O6-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cilengitide - Cilengitide in Treating Children With Refractory Primary Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cilengitide - Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cilengitide - Cilengitide in Treating Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cintredekin Besudotox - Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cisplatin - Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cisplatin - Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cisplatin - Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cisplatin - Chemotherapy and Radiation Therapy in Treating Infants With Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cisplatin - Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cisplatin - Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cisplatin - Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cisplatin - Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma - This study has been completed (Current: 23 Nov 2006)
• Cisplatin - Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cisplatin - Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Neuroectodermal Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cisplatin - Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Astrocytoma - This study has been completed (Current: 23 Nov 2006)
• Cisplatin - Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cisplatin - Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cisplatin - Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors - This study has been completed (Current: 23 Nov 2006)
• Cisplatin - Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cisplatin - Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cisplatin - Intratumoral Transferrin-CRM107 Compared With Best Standard Chemotherapy in Treating Patients With Progressive and/or Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cisplatin - Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma - This study has been completed (Current: 23 Nov 2006)
• Cisplatin - Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cladribine - Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma - This study has been completed (Current: 23 Nov 2006)
• Comparison of two anesthetics protocol - Anaesthesia for Supratentorial Tumor Resection - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Cyclophosphamide - Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Biological Therapy in Treating Patients With Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Sodium Thiosulfate in Treating Patients With High-Grade Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Chemotherapy and Radiation Therapy in Treating Infants With Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors - This study has been completed (Current: 23 Nov 2006)
• Cyclophosphamide - Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma - This study has been completed (Current: 23 Nov 2006)
• Cyclophosphamide - Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Neuroectodermal Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Treating Young Patients With Relapsed or Progressive Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma - This study has been completed (Current: 23 Nov 2006)
• Cyclophosphamide - Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma - This study has been completed (Current: 23 Nov 2006)
• Cyclophosphamide - Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Surgery Plus Radiation Therapy With and Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide - Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cyclosporine - Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma - This study has been completed (Current: 23 Nov 2006)
• Cyproheptadine - Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cytarabine (Liposomal) - Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Cytarabine - Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma - This study has been completed (Current: 23 Nov 2006)
• Cytovene (Ganciclovir Sodium) - Gene Therapy for the Treatment of Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• DTI-015 - Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas - This study has been terminated (Current: 23 Nov 2006)
• Dalteparin - Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
• Decitabine - Decitabine in Treating Patients With Melanoma or Other Advanced Cancer - This study has been completed (Current: 23 Nov 2006)
• Depsipeptide - Phase I Study of Depsipeptide in Children With Cancer - This study has been completed (Current: 23 Nov 2006)
• Dexamethasone - Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma - This study has been completed (Current: 23 Nov 2006)
• Dexamethasone - Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma - This study has been completed (Current: 23 Nov 2006)
• Dexamethasone - Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Dexamethasone - The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer - This study has been terminated (Current: 23 Nov 2006)
• Docetaxel - Docetaxel in Treating Children With Recurrent Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Docetaxel - Thalidomide and Docetaxel in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Donepezil Hydrochloride - Donepezil or EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Doxorubicin hydrochloride - Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma - This study has been completed (Current: 23 Nov 2006)
• Doxorubicin - Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors - This study has been completed (Current: 23 Nov 2006)
• Dronabinol - A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006)
• EGFR antisense DNA - Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• EGb761 - Donepezil or EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006)
• EMD 121974 - Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor) - This study is no longer recruiting patients (Current: 23 Nov 2006)
• EMD 121974 - EMD 121974 in Treating Patients With Progressive or Recurrent Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Ecteinascidin 743 - Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Efaproxiral - Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Enzastaurin Hydrochloride - Enzastaurin in Treating Patients With Recurrent Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006)
• Enzastaurin - LY317615 in Treating Patients With Recurrent Gliomas - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Erlotinib Hydrochloride - Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Erlotinib Hydrochloride - Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Erlotinib Hydrochloride - Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Erlotinib Hydrochloride - Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Erlotinib Hydrochloride - Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Erlotinib Hydrochloride - Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006)
• Erlotinib Hydrochloride - Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Erlotinib, Tarceva, OSI-774 - Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Erlotinib - Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma - This study has been completed (Current: 23 Nov 2006)
• Erlotinib - Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Erlotinib - QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC - This study is currently recruiting patients (Current: 23 Nov 2006)
• Etoposide Phosphate - Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Etoposide Phosphate - Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Sodium Thiosulfate in Treating Patients With High-Grade Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Etoposide Phosphate - Combination Chemotherapy and Blood-Brain Barrier Disruption Followed By Sodium Thiosulfate in Treating Patients With Anaplastic Oligodendroglioma or Oligoastrocytoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Etoposide - Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Sodium Thiosulfate in Treating Patients With High-Grade Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Etoposide - Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Etoposide - Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Etoposide - Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Etoposide - Chemotherapy and Radiation Therapy in Treating Infants With Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Etoposide - Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Etoposide - Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Etoposide - Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma - This study has been completed (Current: 23 Nov 2006)
• Etoposide - Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor - This study is currently recruiting patients (Current: 23 Nov 2006)
• Etoposide - Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Etoposide - Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Etoposide - Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Astrocytoma - This study has been completed (Current: 23 Nov 2006)
• Etoposide - Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma - This study has been completed (Current: 23 Nov 2006)
• Etoposide - Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Etoposide - Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Etoposide - Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Etoposide - Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Treating Young Patients With Relapsed or Progressive Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Etoposide - Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Etoposide - Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Etoposide - Surgery Plus Radiation Therapy With and Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Etoposide - Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Everolimus - AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Everolimus - Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Everolimus - Everolimus and Temozolomide in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006)
• Everolimus - Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors - This study has been suspended (Current: 23 Nov 2006)
• Exatecan Mesylate - DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas - This study has been completed (Current: 23 Nov 2006)
• FR901228 - FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia - This study has been completed (Current: 23 Nov 2006)
• FR901228 - FR901228 in Treating Patients With Recurrent High-Grade Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006)
• Fenretinide - Fenretinide in Treating Patients With Recurrent Malignant Glioma - This study has been completed (Current: 23 Nov 2006)
• Fenretinide - Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Ferumoxytol - Magnetic Resonance Imaging Using Ferumoxytol in Patients With Primary Brain Cancer or Brain Metastases From Lung or Breast Cancer - This study has been suspended (Current: 23 Nov 2006)
• Filgrastim - Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Sodium Thiosulfate in Treating Patients With High-Grade Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma - This study has been completed (Current: 23 Nov 2006)
• Filgrastim - Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Neuroectodermal Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Combination Chemotherapy for Patients With Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas - This study has been completed (Current: 23 Nov 2006)
• Filgrastim - Docetaxel in Treating Children With Recurrent Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Filgrastim - High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma - This study has been completed (Current: 23 Nov 2006)
• Filgrastim - Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma - This study has been completed (Current: 23 Nov 2006)
• Filgrastim - Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Filgrastim - Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors - This study has been completed (Current: 23 Nov 2006)
• Filgrastim - Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Flavopiridol - Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Fludeoxyglucose F 18 - Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Fluorouracil - Combination Chemotherapy in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Fluorouracil - Combination Chemotherapy in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• G207, an oncolytic virus - Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer - This study has been completed (Current: 23 Nov 2006)
• G207 - G207 Followed by Radiation Therapy in Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Gadolinium Texaphyrin - Gadolinium Texaphyrin With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas - This study has been completed (Current: 23 Nov 2006)
• Gadolinium Texaphyrin - Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Gadopentetate Dimeglumine - Diagnostic Study In Patients Receiving Treatment For Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Gadopentetate Dimeglumine - Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Gallium Nitrate - Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors - This study has been completed (Current: 23 Nov 2006)
• Ganciclovir - Gene Therapy in Treating Patients With Primary Brain Tumors - This study has been completed (Current: 23 Nov 2006)
• Gefitinib - A Phase II Exploratory, Multicentre, Open-Label, Non-Comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme - This study has been completed (Current: 23 Nov 2006)
• Gefitinib - Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Gefitinib - Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma - This study has been completed (Current: 23 Nov 2006)
• Gefitinib - Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Gefitinib - ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Gefitinib - ZD 1839 in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Gimatecan - Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma - This study has been completed (Current: 23 Nov 2006)
• Glufosfamide - Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Gp96 Heat Shock Protein-Peptide Complex - GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• HYCAMTIN, oral capsules - Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment of Brain Metastases Resulting From Non-Small Lung Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Hydroxyurea - Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Hydroxyurea - Hydroxyurea in Treating Patients With Unresectable Benign Meningioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Hydroxyurea - Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Hydroxyurea - Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Hydroxyurea - Radiation Therapy in Treating Patients With Glioblastoma - This study has been completed (Current: 23 Nov 2006)
• Hyperbaric Oxygen - Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• IL13-PE38QQR - IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• IL13-PE38QQR - Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• IL13-PE38QQR - The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Ifosfamide - Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Ifosfamide - Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Imatinib Mesylate - Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Imatinib Mesylate - Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Imatinib Mesylate - Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure - This study has been completed (Current: 23 Nov 2006)
• Imatinib Mesylate - Imatinib Mesylate in Treating Patients With Gliomas - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Imatinib Mesylate - Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor - This study has been suspended (Current: 23 Nov 2006)
• Imatinib Mesylate - Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma - This study has been completed (Current: 23 Nov 2006)
• Imatinib Mesylate - Imatinib Mesylate in Treating Patients With Recurrent Meningioma - This study has been completed (Current: 23 Nov 2006)
• Imatinib Mesylate - Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Imatinib Mesylate - Open-Label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Imatinib Mesylate - Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Imatinib mesylate; hydroxyurea - Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Interferon Alfa - Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Interferon Alfa - Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Interleukin-12 - Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Interleukin-13 Pe38Qqr Immunotoxin - Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Interleukin-13 Pe38Qqr Immunotoxin - Immunotoxin Therapy in Treating Patients With Malignant Glioma - This study has been completed (Current: 23 Nov 2006)
• Interleukin-2/Tumor Infiltrating Lymphocytes - Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Interleukin-2 - Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Interleukin-2 - Biological Therapy in Treating Patients With Primary or Advanced Glioma - This study has been suspended (Current: 23 Nov 2006)
• Interleukin-2 - Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Interleukin-2 - Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Interleukin-4 Pe38Kdel Cytotoxin - NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Interleukin-4 Pe38Kdel Immunotoxin - IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Iodine I 125/Polifeprosan 20 With Carmustine Implant - Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma - This study has been completed (Current: 23 Nov 2006)
• Iodine I 125 - Brachytherapy in Treating Patients With Recurrent Malignant Glioma - This study has been completed (Current: 23 Nov 2006)
• Iodine I 125 - Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma - This study has been completed (Current: 23 Nov 2006)
• Iodine I 125 - Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors - This study has been completed (Current: 23 Nov 2006)
• Iodine I 131 Monoclonal Antibody 3F8 - Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer - This study has been suspended (Current: 23 Nov 2006)
• Iodine I 131 Monoclonal Antibody 81C6 - Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Iodine I 131 Monoclonal Antibody 81C6 - Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Iodine I 131 Monoclonal Antibody 81C6 - Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Iodine I 131 Monoclonal Antibody 81C6 - Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers - This study has been completed (Current: 23 Nov 2006)
• Iodine I 131 Monoclonal Antibody 8H9 - Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Iodine I 131 Monoclonal Antibody Tnt-1/B - Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006)
• Iodine I 131 Monoclonal Antibody Tnt-1/B - Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Iressa (Gefitinib) , cytostatic drug, an EGFR-TK inhibitor, p.o 250 mg a day - Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Irinotecan HCL - Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas - This study is currently recruiting patients (Current: 23 Nov 2006)
• Irinotecan Hydrochloride - Bevacizumab and Irinotecan in Treating Patients With Recurrent High-Grade Malignant Glioma That Progressed on Bevacizumab Alone - This study is currently recruiting patients (Current: 23 Nov 2006)
• Irinotecan Hydrochloride - Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006)
• Irinotecan Hydrochloride - Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Irinotecan Hydrochloride - Irinotecan in Treating Children With Refractory Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Irinotecan Hydrochloride - MRI in Patients Receiving Bevacizumab and Irinotecan for Recurrent Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Irinotecan Hydrochloride - Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Irinotecan - Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Irinotecan - Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas - This study has been completed (Current: 23 Nov 2006)
• Irinotecan - Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors - This study has been completed (Current: 23 Nov 2006)
• Irinotecan - Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Irinotecan - Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Irinotecan - Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma - This study has been completed (Current: 23 Nov 2006)
• Irinotecan - Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma - This study has been completed (Current: 23 Nov 2006)
• Irinotecan - Irinotecan in Treating Patients With Recurrent Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Irinotecan - Irinotecan in Treating Patients With Recurrent Malignant Glioma - This study has been completed (Current: 23 Nov 2006)
• Irinotecan - Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Irinotecan - Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Irinotecan - Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Irofulven - Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors - This study has been completed (Current: 23 Nov 2006)
• Isotretinoin - Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Ispinesib - Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Itraconazole - Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation - This study is currently recruiting patients (Current: 23 Nov 2006)
• Ixabepilone - Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Ixabepilone - Ixabepilone in Treating Patients With Recurrent Glioma - This study has been completed (Current: 23 Nov 2006)
• Karenitecin (BNP1350) - Study of Karenitecin (BNP1350) in Patients With Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Karenitecin - Karenitecin in Treating Patients With Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Keyhole Limpet Hemocyanin - Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• LY231514 - Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors - This study has been completed (Current: 23 Nov 2006)
• Lapatinib - Lapatinib in Treating Patients Who Are Undergoing Surgery for Recurrent Progressive Glioblastoma Multiforme or Gliosarcoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Lapatinib - Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006)
• Leflunomide - Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Leflunomide - SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme - This study has been completed (Current: 23 Nov 2006)
• Lenalidomide - Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Leucovorin Calcium - Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Leucovorin Calcium - Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Leucovorin Calcium - Combination Chemotherapy in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Leucovorin Calcium - Combination Chemotherapy in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Leucovorin calcium - The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer - This study has been terminated (Current: 23 Nov 2006)
• Lobradimil - Lobradimil and Carboplatin in Treating Children With Brain Tumors - This study has been completed (Current: 23 Nov 2006)
• Lomustine - Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma - This study has been completed (Current: 23 Nov 2006)
• Lomustine - Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Lomustine - Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Lomustine - Intratumoral Transferrin-CRM107 Compared With Best Standard Chemotherapy in Treating Patients With Progressive and/or Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006)
• Lomustine - Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma - This study has been completed (Current: 23 Nov 2006)
• Lomustine - Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Lomustine - Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Lomustine - Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Lonafarnib - Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006)
• Lonafarnib - SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Lymphokine-Activated Killer Cells - Biological Therapy in Treating Patients With Primary or Advanced Glioma - This study has been suspended (Current: 23 Nov 2006)
• Lymphokine-Activated Killer Cells - Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• MPC-6827 - Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases - This study is currently recruiting patients (Current: 23 Nov 2006)
• MS-275 - MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• MV-CEA - Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006)
• Mafosfamide - Chemotherapy and Radiation Therapy in Treating Infants With Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Mafosfamide - Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Mannitol - Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Mannitol - Combination Chemotherapy and Blood-Brain Barrier Disruption Followed By Sodium Thiosulfate in Treating Patients With Anaplastic Oligodendroglioma or Oligoastrocytoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Mannitol - Melphalan and Mannitol in Treating Patients With Central Nervous System Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Mechlorethamine - Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Megestrol - Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment - This study is currently recruiting patients (Current: 23 Nov 2006)
• Melatonin - Melatonin and Radiation Therapy in Treating Patients With Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Melphalan - Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Melphalan - Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors - This study has been completed (Current: 23 Nov 2006)
• Melphalan - Combination Chemotherapy and Blood-Brain Barrier Disruption Followed By Sodium Thiosulfate in Treating Patients With Anaplastic Oligodendroglioma or Oligoastrocytoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Melphalan - Melphalan and Mannitol in Treating Patients With Central Nervous System Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Melphalan - Melphalan in Patients With Neoplastic Meningitis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Mercaptopurine - Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Mesna - Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma - This study has been completed (Current: 23 Nov 2006)
• Mesna - Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Methotrexate - Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Methotrexate - Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma - This study has been completed (Current: 23 Nov 2006)
• Methotrexate - Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Methotrexate - Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Methotrexate - The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer - This study has been terminated (Current: 23 Nov 2006)
• Methylphenidate - Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Mitolactol - Radiation Therapy in Treating Patients With Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Modafinil - Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Monoclonal Antibody Me1-14 F(Ab')2 - Monoclonal Antibody Therapy in Patients With Primary or Metastatic Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Monoclonal Antibody Me1-14 F(Ab')2 - Monoclonal Antibody Therapy in Treating Patients With Brain Metastases - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Monoclonal Antibody Okt3 - Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Monoclonal Antibody Okt3 - Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Morphine - Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Motexafin Gadolinium Injection - A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006)
• Motexafin Gadolinium - Diagnostic Imaging in Children With Primary Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Motexafin Gadolinium - Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Motexafin Gadolinium - Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Motexafin Gadolinium - Phase II Study of Motexafin Gadolinium and Cranial Irradiation in Patients With Newly Diagnosed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Motexafin Gadolinium - Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Motexafin gadolinium - Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases - This study is currently recruiting patients (Current: 23 Nov 2006)
• Multihance - Multihance at 3 Tesla in Brain Tumors - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Nimustine - Intratumoral Transferrin-CRM107 Compared With Best Standard Chemotherapy in Treating Patients With Progressive and/or Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006)
• Nitrocamptothecin - Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• O-(2-[F-18]Fluorethyl)-L-Tyrosin (FET) - PET - Study on Amino Acid Uptake in Brain Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• O6-benzylguanine - Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain - This study is no longer recruiting patients (Current: 23 Nov 2006)
• O6-benzylguanine - Carmustine Plus O6-Benzylguanine in Treating Patients With Recurrent or Progressive Glioma - This study has been completed (Current: 23 Nov 2006)
• O6-benzylguanine - Carmustine and O6-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• O6-benzylguanine - Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• O6-benzylguanine - Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006)
• O6-benzylguanine - O(6)-Benzylguanine in Treating Patients With Malignant Glioma - This study has been completed (Current: 23 Nov 2006)
• O6-benzylguanine - O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• O6-benzylguanine - O6-Benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• O6-benzylguanine - O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• O6-benzylguanine - Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors - This study has been completed (Current: 23 Nov 2006)
• O6-benzylguanine - Temozolomide and O6-Benzylguanine in Treating Children With Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• O6-benzylguanine - Temozolomide and O6-Benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Octreotide acetate and cabergoline - Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly - This study is currently recruiting patients (Current: 23 Nov 2006)
• Octreotide - Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Oxaliplatin - Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006)
• PEG-interferon alfa-2b - PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent High-Grade Gliomas - This study is currently recruiting patients (Current: 23 Nov 2006)
• Paclitaxel - Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Paclitaxel - Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Paclitaxel - Combination Chemotherapy for Patients With Brain Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Pemetrexed Disodium - Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases - This study is currently recruiting patients (Current: 23 Nov 2006)
• Pemetrexed - Treatment of Brain Metastases From Non-Small Cell Lung Cancer With Brain Radiation and Pemetrexed - This study is currently recruiting patients (Current: 23 Nov 2006)
• Penclomedine - Penclomedine in Treating Patients With Solid Tumors or Lymphoma - This study has been completed (Current: 23 Nov 2006)
• Penicillamine - Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Pentoxifylline - Radiation Therapy in Treating Patients With Glioblastoma - This study has been completed (Current: 23 Nov 2006)
• Phenylacetate - Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors - This study has been completed (Current: 23 Nov 2006)
• Phenylbutyrate - Phenylbutyrate in Treating Children With Progressive or Recurrent Cancer of the Central Nervous System - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Phenylbutyrate - Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors - This study has been completed (Current: 23 Nov 2006)
• Phosphorus P32 - Phosphorus 32 in Treating Patients With Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006)
• Polifeprosan 20 With Carmustine Implant - Carmustine Implants in Treating Patients With Brain Metastases - This study has been completed (Current: 23 Nov 2006)
• Polifeprosan 20 With Carmustine Implant - Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas - This study has been completed (Current: 23 Nov 2006)
• Polifeprosan 20 With Carmustine Implant - Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Polifeprosan 20 With Carmustine Implant - Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006)
• Polifeprosan 20 With Carmustine Implant - Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma - This study has been completed (Current: 23 Nov 2006)
• Polifeprosan 20 With Carmustine Implant - O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Poly Iclc - Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Porfimer Sodium - Photodynamic Therapy Using Porfimer Sodium in Treating Patients Who Are Undergoing Surgery for Recurrent Malignant Astrocytoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Porfimer Sodium - Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Prednisone - Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Prinomastat - Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Procarbazine Hydrochloride - Intratumoral Transferrin-CRM107 Compared With Best Standard Chemotherapy in Treating Patients With Progressive and/or Recurrent Glioblastoma Multiforme - This study is currently recruiting patients (Current: 23 Nov 2006)
• Procarbazine Hydrochloride - Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Procarbazine Hydrochloride - Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Procarbazine - Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma - This study has been completed (Current: 23 Nov 2006)
• Procarbazine - Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Procarbazine - Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Procarbazine - Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Procarbazine - Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Procarbazine - Procarbazine in Treating Patients With Recurrent Brain Tumor - This study has been completed (Current: 23 Nov 2006)
• Procarbazine - Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Procarbazine - SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme - This study has been completed (Current: 23 Nov 2006)

The trial data on this page has been sourced from

• The U.S. National Library of Medicine (NLM) together with ClinicalTrials.gov

 » Next page: External links relating to Brain cancer

Rate This Website

What do you think about the features of this website? Take our user survey and have your say:

Website User Survey

Medical Tools & Articles:

Next articles:

• External links relating to Brain cancer
• Introduction: Malignant Neoplasms (Professional Guide to Diseases (Eighth Edition))
• Malignant brain tumors (Professional Guide to Diseases (Eighth Edition))
• Malignant spinal neoplasms (Professional Guide to Diseases (Eighth Edition))
• Brain tumors, malignant (Handbook of Diseases)

Tools & Services:

• Bookmark this page
• Take a survey relating to Brain cancer
• Symptom Search
• Symptom Checker
• Medical Dictionary
• Give your feedback

Medical Articles:

• Disease & Treatments Search
• Misdiagnosis Center
• Full list of interesting articles

Forums & Message Boards

• Ask or answer a question at the Boards:
• I cannot get a diagnosis. Please help.
• Tell us your medical story.
• Share your misdiagnosis story.
• What is the best treatment for my condition?
• See all the Boards.

Enter your search terms Submit search form
Search The Web Search wrongdiagnosis.com